William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2Gen®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- STEM-Talk: Dr. Barbara Thorne, conehead termite expert, on biology, control of these highly social insects
- Summer Robotics Camp 2023 registration opens this week.
- Space Florida, IHMC partnership includes collaboration, research support
- WATCH: Dr. Karen Wooley on the future of sustainable, biodegradable plastics.
- STEM-Talk: Jeff Volek on what we’ve learned in 30 years about keto, carb-restricted diets and health
- WATCH: Dr. Alexander Fleming’s Evening Lecture on geroscience and healthy longevity
- IHMC breaks ground on new, $30 million human performance research complex
- STEM-Talk: Ed Weiler on the Hubble and James Webb telescopes and NASA’s search for life
- IHMC wins Best Paper award at International Conference on Humanoid Robots 2022